Original news and analysis on international IP policy
A new trademark regulation entered into force in Albania on June 7, 2018, clarifying a range of issues raised by the changes to the Albanian Industrial Property Law in force as of March 24, 2017. Some of the most significant changes and clarifications concern the following:
South Africa’s Portfolio Committee on Trade and Industry in Parliament has published a list of select clauses of the Copyright Amendment Bill for public comment. The deadline for comments is 18 July.
A recent study has revisited the meaning of “public domain” in line with its usage in discussions on protection of traditional knowledge (TK). The study highlights that it provides a non-Eurocentric conception of “public domain” in order to recognise the customary laws and practices of indigenous and local communities (ILCs).
The European Parliament today opposed plans to launch immediate “trilogue” negotiations with the Council and European Commission on copyright reform legislation, instead sending the controversial measure to full debate at the next plenary session of Parliament.
The European Parliament votes tomorrow on whether to allow negotiations with the Council to begin on controversial copyright reform legislation. The proposed updated rules have sparked intense lobbying by supporters and foes alike, including, one lawmaker said at a press briefing today, death threats.
Frederick Abbott writes: Competition law is a critical tool in seeking to maintain some semblance of reasonable pricing in the pharmaceutical market. It is particularly important as legislators around the world appear extremely hesitant to address pharmaceutical pricing in meaningful ways, regrettably influenced by well-funded lobbying.
Two recent competition law decisions discussed below illustrate the importance of and challenges to regulating the pharmaceutical sector. In the first, the UK Competition Appeal Tribunal (CAT) partially upheld and partially reversed and remanded (pending briefing) a decision by the Competition and Markets Authority (CMA) fining Pfizer and Flynn close to £90 million for abuse of dominant position in the excessive pricing of an anti-epilepsy drug. The CAT decision is problematic because it creates unnecessary and unwarranted hurdles to findings of excessive pricing in the UK. In the second decision, the US Federal Trade Commission succeeds in proving that AbbVie engaged in abuse of monopoly power by engaging in sham patent litigation against two generic producers in order to delay market entry of competitive products. The Federal District Court found that AbbVie’s patent lawyers by “clear and convincing” evidence had knowingly pursued patent infringement claims without chance of success for no other purpose than to delay market entry.
Some 145 organisations have signed an open letter urging European Parliament to vote against the Legal Affairs (JURI) Committee mandate to negotiate on copyright reform. The European Parliament will meet on 5 July for a plenary vote on whether or not to endorse the mandate.
A recent event jointly organised by the Graduate Institute Centre for Trade and Economic Integration and the United Kingdom Department for International Trade and its Mission to the WTO brought together several leaders on global trade to discuss the current challenges in trade and how best to address them.
The World Intellectual Property Organization Marrakesh Treaty on copyright exceptions enabling international access to published works by blind and print-disabled readers was ratified this week by the United States Senate, putting it one step closer to final ratification in the country.
eLife, an online publisher of research in the life and biomedical sciences, is trialing a radical new approach to peer review to increase editorial transparency and promote more efficient access to innovative new research.